CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-31 | DE SCHUTTER RICHARD U Director | Grant or award | +1,691 | $18.47 | $31K | 262,635 |
| 2018-12-14 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Purchase | +25,440 | $22.96 | $584K | 128,922 |
| 2018-12-14 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Grant or award | +25,440 | 154,362 | ||
| 2018-10-29 | VON ESCHENBACH ANDREW C. Director | Grant or award | +5,832 | 6,832 | ||
| 2018-10-16 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Sale | −4,542 | $25.50 | $116K | 51,456 |
| 2018-10-15 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Sale | −15,404 | $24.83 | $382K | 55,998 |
| 2018-09-28 | WECHSLER AMY B Director | Grant or award | +1,217 | $25.67 | $31K | 71,449 |
| 2018-09-28 | ROBERTSON RUSSEL C Director | Grant or award | +1,460 | $25.67 | $37K | 75,167 |
| 2018-09-28 | Paulson John Director | Grant or award | +1,071 | $25.67 | $27K | 39,211 |
| 2018-09-28 | DE SCHUTTER RICHARD U Director | Grant or award | +1,217 | $25.67 | $31K | 260,944 |
| 2018-09-14 | Herendeen Paul EVP and CFO | Purchase | +10,000 | $22.61 | $226K | 216,866 |
| 2018-09-14 | Herendeen Paul EVP and CFO | Grant or award | +10,000 | 226,866 | ||
| 2018-09-14 | PAPA JOSEPH C CHAIRMAN & CEO | Purchase | +30,000 | $22.32 | $670K | 657,077 |
| 2018-09-14 | PAPA JOSEPH C CHAIRMAN & CEO | Grant or award | +30,000 | 687,077 | ||
| 2018-09-13 | DE SCHUTTER RICHARD U Director | Purchase | +125,000 | $23.96 | $3.0M | 259,727 |
| 2018-08-23 | Herendeen Paul EVP and CFO | Shares withheld for taxes | −24,626 | $22.37 | $551K | 206,866 |
| 2018-08-20 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −6,604 | $21.69 | $143K | 103,482 |
| 2018-08-20 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −5,501 | $21.69 | $119K | 104,585 |
| 2018-08-09 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −7,779 | $23.52 | $183K | 71,402 |
| 2018-06-29 | DE SCHUTTER RICHARD U Director | Grant or award | +1,344 | $23.24 | $31K | 134,727 |
Page 34 of 37 · 734 trades